Research Papers:

Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells

Feng Wei _, Lijuan Ding, Zhentong Wei, Yandong Zhang, Yang Li, Luo Qinghua, Yuteng Ma, Liang Guo, Guoyue Lv and Yan Liu

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:85259-85272. https://doi.org/10.18632/oncotarget.13269

Metrics: PDF 2442 views  |   HTML 3078 views  |   ?  


Feng Wei1, Lijuan Ding1, Zhentong Wei4, Yandong Zhang1, Yang Li1, Luo Qinghua2, Yuteng Ma1, Liang Guo5, Guoyue Lv1, Yan Liu2,3

1Department of Hepatobiliary & Pancreas Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China

2Genetic Engineering Laboratory of PLA, The Eleventh Institute of Academy of Military Medical Sciences of PLA, Jilin 130122, P.R. China

3Department of Pathophysiology, Basic College of Medicine, Jilin University, Changchun, Jilin 130021, P.R. China

4Oncologic Gynecology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China

5Pathology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China

Correspondence to:

Yan Liu, email: [email protected]

Guoyue Lv, email: [email protected]

Keywords: RPL34, pancreatic cancer, MAPK, metastasis, ingenuity pathway analysis

Received: April 27, 2016    Accepted: October 19, 2016    Published: November 10, 2016


Ribosomal proteins (RPs) are the main components of ribosomes and participate in the self-assembly of ribosomes and protein synthesis. Recent advance has shown that RPs play important roles in the tumorigenesis and drug resistance of various cancers. However, the expression status and function of RPL34 in pancreatic cancer (PC) remains unclear. In this study, we find that RPL34 is overexpressed in PC tissues and cell lines, which is correlated with decreased methylation of its promoter. Knockdown of RPL34 effectively suppresses the proliferation, colony formation, migration and drug-resistance of PC cells, which are accompanied by cell cycle arrest at the G2 phase and induction of apoptosis. In vivo assays demonstrate that RPL34 silencing inhibits PC tumor growth and metastasis. Moreover, gene expression profiling revealed that RPL34 silencing results in alteration of the MAPK and p53 signaling pathways. Clinically, our data indicate a positive association of RPL34 expression with tumor stage and metastasis in PCs. We revealed that RPL34 acts as a potential onco-protein in PC, and RPL34 may be a promising biomarker for prognosis prediction and a potential target for the treatment of PC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13269